Clinical trial registry record

Improving Physical Ability and Cellular Senescence Elimination in HIV

A registered PHASE2 study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Registry ID
NCT07144293
Last registry update
September 10, 2026
Status
Completed
Phase
PHASE2
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Enrollment
82
Countries
United States
Match confidence
80%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered PHASE2 study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record matched · 80% confidence

Published automatically with 80% topic confidence after controlled-term evaluation.

  • Senolytics · 80%Legacy trial evaluated automatically against controlled title, summary, and longevity-context rules.

Source quality 100% · freshness 100%. These are automated routing signals, not medical or evidence-strength ratings.